(Q38074572)

28 August 2017

1 reference

title

The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease (English)

1 reference

28 August 2017

Hans-Joachim Anders

1

1 reference

28 August 2017

Kirstin Andersen

series ordinal

2

1 reference

28 August 2017

Bärbel Stecher

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

16 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

83

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

1010-1016

1 reference

The dialog between microbiota and the immune system: Shaping the partners through development and evolution

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

A human gut microbial gene catalogue established by metagenomic sequencing

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Microbial translocation across the GI tract

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Interactions between the microbiota and the immune system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Intestinal microbiota determine severity of myocardial infarction in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Gut Microbiota in Health and Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

The emerging role of the gut in chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

The gut microbiota shapes intestinal immune responses during health and disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Peripheral education of the immune system by colonic commensal microbiota.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Induction of intestinal Th17 cells by segmented filamentous bacteria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Pathobionts of the gastrointestinal microbiota and inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Host-bacteria homeostasis in the healthy and inflamed gut.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Diet, gut microbiota and immune responses

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Inflammation in end-stage renal disease--a fire that burns within

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Aspects of immune dysfunction in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

The pathogenesis of sepsis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Monocyte subpopulations and cardiovascular risk in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Inflammation in end-stage renal disease--what have we learned in 10 years?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

The gut: the forgotten organ in uremia?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Intestinal bacterial microflora--a potential source of chronic inflammation in patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Interactions between commensal intestinal bacteria and the immune system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Commensal flora and the regulation of inflammatory and autoimmune responses.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Innate pathogen recognition in the kidney: toll-like receptors, NOD-like receptors, and RIG-like helicases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Toll-like Receptor 4 Polymorphisms and Atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-α-mediated podocyte loss

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Coactivation of Toll-like receptor-3 and -7 in immune complex glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Colonic contribution to uremic solutes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2012.440

1 reference

7 January 2021

In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

AST-120 treatment in pre-dialysis period affects the prognosis in patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

The inflammasomes in kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Effect of uremia on structure and function of immune system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Vaccination and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Endotoxin tolerance: new mechanisms, molecules and clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

The sepsis seesaw: tilting toward immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Sodium butyrate prevents lethality of severe sepsis in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Oxidative stress in uremia: nature, mechanisms, and potential consequences

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Impaired phagocytosis in dialysis patients: studies on mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Molecular aspects of T- and B-cell function in uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Naïve and central memory T-cell lymphopenia in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.440

7 January 2021

Identifiers

DOI

10.1038/KI.2012.440

1 reference

Dimensions Publication ID

28 August 2017

1007643532

0 references

1 reference